1-11 of 11
Helen Heslop
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and efficacy of MT-601 in relapsed or refractory (r/r) Hodgkin lymphoma

Free
Haitham Abdelhakim, Geoffrey Shouse, Manali Kamdar, Priyanka Pophali, Samuel Yamshon, Luke Mountjoy, Aravind Ramakrishnan, Ian Flinn, Akiva Diamond, Margaret Gilbert, Maria-Bernadette Madel, Laura Angelo, Hettie Stein, Deb Chapman, Patricia Allison, John Gutheil, Teresa Melink, Susie Bergman, Mary Newman, Helen Heslop, Malcolm Brenner, Premal Lulla, Monic Stuart, Juan Vera
Journal: Blood
Blood (2025) 146 (Supplement 1): 1846.
https://doi.org/10.1182/blood-2025-1846
Published: 2025
Journal Articles

MT-601 demonstrates favorable safety and durable responses in relapsed or refractory (r/r) non-Hodgkin lymphoma (NHL)

Free
Geoffrey Shouse, Samuel Yamshon, Manali Kamdar, Haitham Abdelhakim, Priyanka Pophali, Luke Mountjoy, Aravind Ramakrishnan, Ian Flinn, Akiva Diamond, Margaret Gilbert, Maria-Bernadette Madel, Laura Angelo, Hettie Stein, Deb Chapman, Patricia Allison, John Gutheil, Teresa Melink, Susie Bergman, Mary Newman, Helen Heslop, Malcolm Brenner, Premal Lulla, Monic Stuart, Juan Vera
Journal: Blood
Blood (2025) 146 (Supplement 1): 5944.
https://doi.org/10.1182/blood-2025-5944
Published: 2025
Journal Articles

Autologous CD30.CAR-T-cell therapy in patients with relapsed or refractory classical Hodgkin lymphoma – long term update of the chariot trial

Free
Sairah Ahmed, Jinwen Cao, Matthew Mei, Amer Beitinjaneh, Helen Heslop, Maryam Alasfour, Mohamed Iburahim Haja Maideen, Omnia Farahat, Adam Braun, Peter Riedell, Natalie Grover, Carlos Ramos
Journal: Blood
Blood (2025) 146 (Supplement 1): 1844.
https://doi.org/10.1182/blood-2025-1844
Published: 2025
Journal Articles

CLL-1 chimeric antigen receptor T-cells for the treatment of Acute Myeloid Leukemia: A phase 1 clinical trial

Free
Erin Doherty, LaQuisa Hill, Daniil Shmidt, Mengfen Wu, Tao Wang, Bambi Grilley, George Carrum, Premal Lulla, Carlos Ramos, John Craddock, Bahey Salem, Gabriela Llaurador Caraballo, Robert Krance, Caridad Martinez, Helen Heslop, Malcolm Brenner, Maksim Mamonkin
Journal: Blood
Blood (2025) 146 (Supplement 1): 2372.
https://doi.org/10.1182/blood-2025-2372
Published: 2025
Journal Articles

Provider practices and preparedness for gene therapy in pediatric sickle cell disease: A national survey of pediatric hematologists

Free
Cecile Karsenty, Titilope Fasipe, Venee N. Tubman, Anil George, Khaled Yassine, Allistair Abraham, John Horan, Helen Heslop, Alexander Ngwube
Journal: Blood
Blood (2025) 146 (Supplement 1): 4378.
https://doi.org/10.1182/blood-2025-4378
Published: 2025
Journal Articles

Long term follow up autologous CD30.CAR-T cells in combination with nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma after failure of frontline therapy

Free
Sairah Ahmed, Matthew Mei, Jinwen Cao, Amer Beitinjaneh, Helen Heslop, Maryam Alasfour, Omnia Farahat, Mohamed Iburahim Haja Maideen, Adam Braun, Daniel Reef, Peter Riedell, Natalie Grover, Carlos Ramos
Journal: Blood
Blood (2025) 146 (Supplement 1): 5938.
https://doi.org/10.1182/blood-2025-5938
Published: 2025
Journal Articles

Definitions of histocompatibility typing terms

Free
e-blood
Eduardo Nunes, Helen Heslop, Marcelo Fernandez-Vina, Cynthia Taves, Dawn R. Wagenknecht, A. Bradley Eisenbrey, Gottfried Fischer, Kay Poulton, Kara Wacker, Carolyn Katovich Hurley, Harriet Noreen, Nicoletta Sacchi
Journal: Blood
Blood (2011) 118 (23): e180–e183.
https://doi.org/10.1182/blood-2011-05-353490
Published: 2011
Journal Articles

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

Free
J. Vera, MD, C. Quintarelli, PhD, B. Savoldo, MD, G. Giordano, PhD, A. Foster, PhD, M. Pule, MD, Helen Heslop, MD, C. Rooney, PhD, Malcolm Brenner, MD, PhD, G. Dotti, MD
Journal: Blood
Blood (2006) 108 (11): 1721.
https://doi.org/10.1182/blood.V108.11.1721.1721
Published: 2006
Journal Articles

High Incidence but Low Morbitiy of Early Cytomegalovirus (CMV) Infections Following Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation with Alemtuzumab and Ganciclovir Prophylaxis.

Free
Renu Lamba, MD, George Carrum, MD, Robert Krance, MD, Helen Heslop, MD, Malcolm Brenner, MD, Uday Popat
Journal: Blood
Blood (2004) 104 (11): 5098.
https://doi.org/10.1182/blood.V104.11.5098.5098
Published: 2004
Journal Articles

Multiple Integration Events into Several Putative Oncogenes Was Required To Cause Leukemogenesis in Two Primate Recipients of RCR Contaminated Stem-Cells.

Free
Martin A. Pule, MD, Alexandra Rousseau, MD, Elizabeth Kang, MD, Takahiro Ueda, MD, Christof von Kalle, Arthur W. Nienhuis, MD, Helen Heslop, MD, Elio Vanin, PhD, John F. Tisdale, MD
Journal: Blood
Blood (2004) 104 (11): 2102.
https://doi.org/10.1182/blood.V104.11.2102.2102
Published: 2004
Journal Articles

Graft-versus-yogurt

Free
Helen Heslop
Journal: Blood
Blood (2004) 103 (11): 4000–4001.
https://doi.org/10.1182/blood-2004-03-1096
Published: 2004